Partner

Maurice Koopmans

Experience in M&A for more than 10 years. Involved in 100+ mid-corporate national and international valuations and deals. Industry expertise in Healthcare. ADR-specialist (mediation & negotiation).

Leader of Healthcare, Biotech & Pharma Industry Group.

Industry experience:

Business services; Education and training; Government; Healthcare; Life sciences; Media, printing, and publishing; Real estate & facility management; Recycling; Security; Trade; Wholesale.

Managing Director

Alan Kelly

Alan has 25 years’ experience working in start-ups, SMEs and multi-million euro organisations.
Having started his career at Deloitte, Alan then worked as FC of KWE Ireland, a Japanese Logistics Company specializing in services to the Pharmaceutical and Electronics Industries. Alan was appointed General Manager of KWE Ireland in 2003 and oversaw revenue growth from €12m to €20m in 2.5 years.
Alan then joined Fonua, Europe’s largest mobile phone distributor as Commercial Director with responsibility for Operations, Finance & Business Development.
Since 2016, Alan has been a Director of FOCUS Capital Partners and has led a number of equity fundraising projects in multiple sectors.
He currently heads up the M&A Department and has successfully completed transactions (sell side & buy side) in multiple sectors including technology, software, healthcare, manufacturing & distribution.
Alan is an active member of M&A Worldwide and is a co-leader of the Healthcare Industry Group.

Co-leader of the Healthcare, Biotech & Pharma Industry Group. 

Industry experience:

Business services; Clean technology; Education and training; Electronics; Energy & renewables; Healthcare; Information technology; Telecom; Transport & logistics.

Managing Partner

Cigdem Bicik

Before founding Crossborder in 2006 Çiğdem worked in the Development and investment banking business for 17 years. She holds an MSc from Loughborough University a BA and MBA in Finance from Istanbul University and is a graduate of the German Gymnasium in Istanbul. She speaks fluent English and German.

Industry experience:

Aerospace & defense; Agriculture; Automotive; Building & construction; Business services; Chemicals; Education and training; Electronics; Energy & renewables; Engineering; Financial services; Food; Government; Hotels & restaurants; Information technology;  Luxury goods; Media, printing, and publishing; Plastics; Real estate & facility management; Retail and franchising; Steel, metal, and woodworking; Telecom; Textile & clothing; Trade; Transport & logistics.

Member of Healthcare Biotech & Pharma Industry Group.

Partner

Didier Busquet

Didier leverages 29 years of experience and over 90 missions completed. Retail, services, and impact investing specialist.

Member of the Healthcare, Biotech & Pharma Industry Group

Industry experience:

Business services; Education and training; Food; Retail and franchising.

Managing Partner

Laurent Choppe

Laurent leads Cukierman & Co. Life Sciences since 2008 and has been involved in more than 100 Medtech and Biotech corporate finance transactions and advisory assignments for the Cukierman group. His team works worldwide with venture-backed and middle-market companies for fundraising, licensing deals and M&A transactions as well as strategic projects for key life sciences industry players.

Laurent brings extensive international life sciences experience in managing multifunctional teams and setting up new businesses in pharmaceuticals, medical devices, biotechnology, nutraceuticals, animal health and direct-to-consumer markets.

Member of Healthcare, Biotech & Pharma Industry Group

Director - Strasbourg

Bertrand Dufay

HSBC Global Banking and Markets: Corporate Coverage for Large Caps (CAC 40 or private groups) with a focus on Automotive (Renault / Michelin) and Healthcare (Sanofi / Servier).BNP Paribas Germany (Corporate & Investment Banking): Corporate Coverage on Mid Caps (Mittelstand)/Emerging Markets.

Industry experience:

Automotive; Healthcare.

Member of Healthcare, Biotech & Pharma Industry Group. 

Analyst Corporate Finance

Tom Moonen

MSF in Finance and BSc in Accounting from Middle Tennessee State University. Former Student-Athlete. Joined Aeternus in 2021.

Member of Healthcare, Biotech & Pharma Industry Group

Director

Iwona Penwarden

16 years experience in corporate finance advisory, ECM, M&A and leading venture capital in Poland. Managing over 50 local and international (ECM, M&A) transaction advisory projects. Managing ECM department awarded by independent organizations in Poland (1st-3rd place among Authorized Advisers in 2010-2013).

Industry experience:

Advertising, PR & marketing; Beverages; Food; Healthcare; Information technology; Insurance; Recycling; Trade.

Member of the Advanced Manufacturing and the Healthcare, Biotech & Pharma Industry Group.

Corporate Finance Associate Director

Joe Powell

Joe joined Rickitt Mitchell in 2021 and during his M&A career to date has advised on several transactions including acquisitions, disposals, PE-Backed MBOs and growth fundraising on the debt market. Recent transactions include the sale of UK based TMT business Spyder to Digital Colony in the US and the sale of Stobart Rail to German PE house, Bavaria Industries.

Member of Healthcare, Biotech & Pharma Industry Group

Industry experience:

Beverages; Energy & renewables; Leisure; Life sciences; Telecom; Transport & logistic.

Partner

Marcos Hiran Silva

Working in financial advisory and M&A for 20+ years. Joined Cypress in 2007. Previously worked in M&A and strategic planning at Telefonica and Strategy Consulting at Booz Allen Hamilton. BSc. in Mechanical Engineering from Unicamp and MBA degree in General Management from Business School São Paulo (BSP).

Industry experience:

Advertising, PR & marketing; Agriculture; Automotive; Beverages; Chemicals; Electronics; Food; Healthcare; Information technology; Plastics; Retail and franchising; Telecom

Member of Healthcare, Biotech & Pharma Industry Group.

Managing Director

Eric Yetter

Investment banker focused on healthcare. His practice includes healthcare services, outsourced services, medical devices, and healthcare IT. Has completed a variety of healthcare transactions, many with private equity firms and PE-backed companies. His past clients include leading physician groups, healthcare facilities, and institutional healthcare investors.

Founded Physicians First in 2016, recognizing the emerging need for investment banking and advisory services for owners of physician practices, surgery centers and clinical businesses. The next four years saw record levels of physician-owner M&A activity and Physicians First became one of the nation’s most active advisors for transactions between private equity firms and medical practices. In 2021, Eric Yetter agreed to merge Physicians First with FOCUS and lead the firm’s healthcare team.

Also has healthcare operating and investing experience. He was an early executive at Covenant Physician Partners (previously Covenant Surgical Partners), an acquirer and operator of ambulatory surgery centers and physician practices. The company built and operated an outsourced laboratory, an anesthesia business, and a revenue cycle management company. Covenant has grown into a major player in healthcare services and is currently backed by private equity firm KKR.

Prior to Covenant, Eric held operating roles at Volkswagen Group of America and Brainlab, Inc., an image-guided surgery company. While at Brainlab, worked with leading neurosurgeons and hospitals to implement cutting edge technology and improve patient outcomes.

He is a licensed attorney (currently inactive) and earned JD and BS degrees from Vanderbilt University, graduating with high honours; and a FINRA licensed investment banker.

Member of Healthcare, Biotech & Pharma Industry Group.

Partner

Dr. Holger Wiemann

Ph. Economics, Cologne, Munich, Paris.Over 25 years in media, digital, internet, software, health. More than 10 years of tech investments, board positions, consulting & restructuring, national & cross-border M&A. Managing Director and CEO of London, Paris, Corporate P&L responsibility exceeding 3-digit Mill. EUR

Industry experience:

Education and training; Healthcare; Information technology; Media, printing, and publishing.

Member of Healthcare, Biotech & Pharma Industry Group.

Director

Martin Gray

Skilled in mergers and acquisitions, business disposals, finance raisings, project finance, independent expert reports, valuations, and due diligence, with substantial listed and private company lead advisory experience. Martin has over 20 years of corporate finance experience in Asia, New Zealand and Europe.

Industry experience:

Agriculture; Beverages; Education and training; Food; Healthcare.

Member of the Healthcare, Biotech & Pharma Industry Group.

Associate

Igor Neumann

• Strategic company and market analysis
• Stakeholder management throughout the M&A process, coordination of internal and external expert teams
• Organisation and execution of due diligence, data room and other transaction services.

Member of the Healthcare, Biotech & Pharma Industry Group.

Partner

Eduardo Gómez de la Torre

Over 27 years of experience in Investment Banking and Corporate Finance. Before joining Misti Capital, he held different positions in Credicorp Group, including BCP’s Corporate and International Banking Division Manager and Regional Head of the Investment Banking team of Credicorp Capital. He has led hundreds of corporate financings, as well as M&A transactions and capital market issuances. He built the Investment Banking team at Scotiabank Peru and he previously worked in the Investment Banking team at Deutsche Bank in New York.

Industry experience:

Beverages; Education and training; Energy & renewables; Financial services; Steel, metal and wood working.

Member of the Consumer & Retail, Energy Environment & Cleanch and the Healthcare, Biotech & Pharma Industry Groups.